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Abstract
Background: Freezing of gait is a common and debilitating symptom affecting many patients with advanced Parkinson’s
disease. Although the pathophysiology of freezing of gait is not fully understood, a number of observations regarding the
pattern of gait in patients with this symptom have been made. Increased ‘Stride Time Variability’ has been one of the most
robust of these features. In this study we sought to identify whether patients with freezing of gait demonstrated similar
fluctuations in their stepping rhythm whilst performing a seated virtual reality gait task that has recently been used to
demonstrate the neural correlate of the freezing phenomenon.
Methods: Seventeen patients with freezing and eleven non-freezers performed the virtual reality task twice, once whilst ‘On’
their regular Parkinsonian medication and once in their practically defined ‘Off’ state.
Results: All patients displayed greater step time variability during their ‘Off’ state assessment compared to when medicated.
Additionally, in the ‘Off’ state, patients with freezing of gait had greater step time variability compared to non-freezers. The
five steps leading up to a freezing episode in the virtual reality environment showed a significant increase in step time
variability although the final three steps preceding the freeze were not characterized by a progressive shortening of latency.
Conclusions: The results of this study suggest that characteristic features of gait disturbance observed in patients with
freezing of gait can also be demonstrated with a virtual reality paradigm. These findings suggest that virtual reality may
offer the potential to further explore the freezing phenomenon in Parkinson’s disease.
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Introduction
Freezing of gait (FOG) is a debilitating symptom that affects
over 50% of patients with advanced Parkinson’s disease (PD) [1].
This paroxysmal phenomenon is defined by the absence or
marked reduction in forward progression of the feet despite the
intention to walk [2]. This symptom impairs mobility, may lead to
falls and is associated with nursing home placement and a
decreased quality of life [3–5].
Previous studies have identified that those PD patients who
suffer from FOG display specific changes in gait, most notably
having a generally increased stride time variability [6–8]. The
stride time variability measures stride-to-stride fluctuations in gait
and is derived from the coefficient of variability (CV), where
CV=100*Standard Deviation/Mean. It is believed to reflect the
ability to produce rhythmical stepping movements without the
need for conscious control [9]. A high stride time variability value
is predictive of worse postural instability and an increased risk of
falls [10]. Compared to non-freezers, patients with FOG have
greater stride time variability, even when discounting discrete
episodes of FOG during clinical assessment [8]. In addition, the
stride time variability is partially ameliorated by dopaminergic
medication in PD with increased variability being reported in the
‘Off’ state [7–10].
Previously, Moreau et al [11] have described an increased stride
length variability in the five steps preceding a freezing episode. It is
possible that a proportion of this variability may be related to the
reported ‘sequence effect’, where there is a reduction in stride
length in the three steps directly preceding an episode of FOG
episode [12,13].
To better understand the freezing phenomenon, our group has
developed a Virtual Reality (VR) task in which subjects navigate a
realistic three-dimensional environment presented in the first
person by using foot pedals to control their ‘walking’. Initial work
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with this paradigm demonstrated that a number of measures,
including the longest spontaneous pause in stepping were
significantly correlated with self-reported symptoms of FOG
[14]. Subsequently, the amount of freezing recorded by this VR
task has been correlated with actual FOG during timed up-and-go
(TUG) tasks [15]. Furthermore, the VR paradigm has been
utilized in combination with functional Magnetic Resonance
Imaging (fMRI) to demonstrate the neural correlates underlying
freezing behaviour [16,17] and the effects of dual-tasking in
patients with FOG [18].
Although the VR task does not directly allow for the calculation
of true stride parameters, it does record step time variability, which
is an objective measure of the dynamic rhythm of motor activity in
the lower limbs. We hypothesized that the VR task would
reproduce the key features of gait variability in PD patients.
Specifically, we predicted: i) that step time variability (STVVR)
would be greater in all patients during their ‘Off’ state; ii) that
patients with FOG would have an increased STVVR when
performing the VR task compared to non-freezers; iii) that there
would be an increased STVVR in the five steps preceding a
freezing episode compared to five consecutive steps that were
unrelated to freezing; and iv) that there would be a progressive
shortening in the step latency in the three steps directly preceding
a VR freezing episode.
Methods
Patient Details
A total of 28 patients with idiopathic PD were recruited for this
study from the Parkinson’s Disease Research Clinic at the Brain
and Mind Research Institute, University of Sydney. All patients
satisfied UKPDS Brain Bank criteria and were deemed unlikely on
MDS guidelines to have dementia [19] or major depression
according to DSM-IV [20]. For reporting purposes we included
the Mini Mental State Examination (MMSE) and Beck’s
Depression Inventory version-II (BDI). Motor severity was
assessed on the motor sub-score of the Unified Parkinson’s Disease
Rating Scale (UPDRS-III) [21]. Finally, the Levodopa Equivalent
Daily Dose (LEDD) was calculated for each patient [22].
Freezers were identified by self-reported freezing behaviour
(positive response to item three of the Freezing of Gait
Questionnaire: ‘‘Do you feel that your feet get glued to the floor
while walking, making a turn or when trying to initiate walking
(freezing)?’’) [23] and clinically observed freezing behaviour by a
neurologist (SJGL). The Freezing of Gait Questionnaire (FOG-Q)
was included in the analyses for reporting purposes. Patients were
assessed twice, once during their practically-defined ‘Off’ state
following overnight withdrawal of anti-Parkinson medication and
once whilst on their regular PD medication (defined as the ‘On’
state). The time between the two measurements was at least two
weeks (average of nine weeks) and the order of assessment was
randomized.
Ethics Statement
This study was approved for by The University of Sydney
Human Research and Ethics Committee and has therefore been
performed in accordance with the ethical standards laid down in
the 1964 Declaration of Helsinki. Written informed consent was
obtained from all subjects.
Virtual Reality Task
The VR task consisted of a three-dimensional virtual environ-
ment presented in the first-person on a computer screen. This was
comprised of a straight corridor without any distracting cues
except for wide ‘doorways’ (see Figure 1). Left and right foot pedals
had to be depressed alternately , 30 degrees below parallel to
activate a trigger mechanism built into the foot pedals. This led to
‘physiological’ footstep sequences (i.e. left-right-left-right), which
resulted in forward progression in the virtual environment.
Patients were instructed to tap the pedals in a rhythm consistent
with their normal gait (,2 Hz) and to start tapping in response to
a ‘WALK’ cue at the start of the task, and to cease this movement
when a ‘STOP’ cue appeared at the end of the task. Both of these
cues were presented at the bottom third of the screen in the
colours green and red respectively. Further details are described in
detail elsewhere [16,17], however the major difference from the
other published studies was that in this experiment patients were
not presented any other cues, thus avoiding environmentally
salient features (such as narrow doorways and turns) and any dual-
task component. To familiarize the patients with the task, they
performed a brief (,1 minute) practice session before performing
the experimental trial.
Measures
The virtual reality program logged subject-independent time
points (in seconds), such as the presentation of a simple WALK or
STOP cue and the presence of a wide doorway. The steps
associated with navigating a wide doorway were excluded from the
analyses. The program also logged subject-dependent time points
associated with the depression of a foot pedal. This allowed for the
calculation of footstep latencies (time in seconds between two
subsequent foot pedal depressions) associated with the successful
completion of two steps (left-right), as well as any out-of-sequence
footsteps (left-left or right-right), which were excluded from all
analyses. For each subject the average footstep latencies of the left
foot were compared to those of the right foot during both
medication states. Step time variability in the VR was calculated as
the step-to-step variability in footstep latencies by using the
coefficient of variation (Coefficient of Variation= 100*Standard
Deviation/Mean) [24]. The coefficient of variation is a measure
that has been employed previously to quantify the temporal
variability of human gait in several populations, such as older
adults [25], elderly that experience frequent falls [26], patients
with dementia [27], as well as in PD patients [6–9,24].
Figure 1. Representation of the virtual corridor in the Virtual
Reality gait task including a wide ‘doorway’ and a ‘walk’ cue.
doi:10.1371/journal.pone.0066718.g001
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Footstep latencies were also used to calculate each patient’s
modal footstep latency. This was derived from an individual’s most
frequent footstep latency whilst performing the VR gait task (as
grouped into bins of 0.1 seconds). This footstep latency mode was
taken as the most accurate measure of the cadence of natural
stepping [15,17,18]. For each patient, footstep latencies greater
than twice their modal footstep latency were defined as VR
freezing episodes [15,17,18]. The percentage time spent with
freezing (%FOG) was calculated from the time spent with VR
freezing in relation to the total time spent performing the task.
This gait metric has recently been proposed as a more reliable
measure of freezing behaviour than simply recording the number
of events [28].
To explore the STVVR of the five steps preceding a VR freezing
episode, a similar method was used as described in the study by
Moreau et al [11]. That study showed that in freezers in their ‘Off’
state, the five steps preceding a freeze were characterized by an
increased stride-length variability compared to five randomly
selected steps that were unrelated to a freezing episodes [11].
Similarly, we used the STVVR to compare the five steps preceding
a VR freezing episode (pre-FOG) with an equal number of
random steps that were not associated with a wide doorway or VR
freezing episode (non-FOG) in freezers in their ‘Off’ state. Finally,
the footstep latencies of the three steps directly preceding a VR
freezing episode were explored for a possible sequence effect by
looking at the step latency.
Data Analysis
Data analysis was performed using IBM Statistical Package for
the Social Sciences (SPSS) version 20. A Chi-square test was used
for gender as it was categorized as a dichotomous variable. The
other demographic group differences were analyzed with a
multivariate analysis of variance (MANOVA), using the Pillai’s
Trace as the overall significance test. The MMSE, BDI and FOG-
Q scores were not included in the MANOVA due to a non-normal
data distribution. Instead, a Mann-Whitney U test was used to
compare the groups for these scores.
The STVVR and %FOG data also violated the normality
assumptions and therefore non-parametric tests were used. A
Mann-Whitney U test was used to compare these measures
between the groups and a Wilcoxon signed rank test was used to
analyze the differences between the ‘On’ and ‘Off’ states within
the groups and to compare the STVVR of the five steps prior to a
VR freeze (pre-FOG) with five consecutive steps that were not
confounded by a freezing episode or other triggers (non-FOG). To
ensure that there were no relationships between the STVVR and
the scores on the MMSE, a Spearman’s rho correlation analysis
was performed.
Finally, a paired samples t-test was used to compare the modal
footstep latencies within the groups between the ‘On’ and ‘Off’
states and to compare the average step times between the left- and
the right foot.
The hypotheses were tested one-sided, as it was postulated a
priori that both freezers and non-freezers would have a greater
STVVR with more VR freezing in their ‘Off’ state [7–10]; that
freezers would show a greater STVVR and have more VR freezing
compared to non-freezers [8]; that the pre-FOG steps would have
greater STVVR than the non-FOG steps [11]; and that the
footstep latencies of the three steps prior to a VR freezing episode
would show a sequence effect related to latency [13]. Alpha levels
were set at 0.05.
Results
Demographic Statistics
The demographics are presented in Table 1. The groups (17
freezers and 11 non-freezers) were matched for age, disease
duration, Hoehn and Yahr stages, LEDD, UPDRS-III ‘Off’ and
‘On’ medication state assessments and modal footstep latencies in
both the ‘Off’ and ‘On’ state (F (8,19) = 1.089, p = 0.412). The
non-significant difference between the UPDRS-III ‘Off’ states was
further reduced when excluding item 29 regarding gait (Freezers:
Mean (SD) = 28.2 (12); Non-freezers: Mean (SD) = 20.7 (10), t
(26) = 1.67, p= 0.106). Fifteen freezers were male (Chi2 (1) = 9.94,
p,0.01) and eight non-freezers were male (Chi2 (1) = 2.27,
p = 0.132). Freezers scored significantly higher on the FOG-Q
(U=3.50, Z=24.25, p,0.001), had similar BDI scores (U=56.5,
Z=21.74, p = 0.081), but scored significantly lower on the
MMSE (U=52.0, Z=22.02, p= 0.044) compared to non-
freezers.
The modal footstep latencies were similar between the ‘Off’ and
‘On’ states for both groups (freezers: t (26) =21.97, p = 0.067;
non-freezers: t (10) = 0.141, p = 0.891). Finally, the average step
times between the left- and right foot were the same for both
groups in both the medication states (freezers ‘Off’: t (16) = 1.825,
p = 0.089; freezers ‘On’: t (16) = 1.462, p = 0.163; non-freezers
‘Off’: t (10) = 1.301, p = 0.222; non-freezers ‘On’: t (10) = 1.264,
p = 0.235).
Virtual Reality Freezing
Freezers had more percentage time frozen (%FOG) than non-
freezers in the ‘Off’ state (U (27) = 58.5, Z=21.65, p = 0.049),
while no group difference was found in the ‘On’ state (U (27) = 83,
Z=20.50, p = 0.309). Freezers showed a higher %FOG in their
‘Off’ state compared to their ‘On’ state (Z (16) =21.76, p = 0.039).
This difference was not found between the medication states for
non-freezers (Z (11) =20.059, p = 0.477).
Step Time Variability in the VR
The results of the step time variability analyses are presented in
Table 2. Each subject took more than 280 steps during each VR
trial (Mean (SD) = 560 (6.2)). A greater STVVR was confirmed in
the ‘Off’ state compared to the ‘On’ state for both freezers and
non-freezers. Moreover, freezers showed a significantly greater
STVVR compared to non-freezers in their ‘Off’ state. Freezers also
showed greater STVVR in the ‘On’ state however, this result did
not reach statistical significance. Finally, no significant correlations
were found between the STVVR and the MMSE scores for both
freezers and non-freezers in their ‘Off’ and ‘On’ states (freezers
‘Off’: r =2.103, Freezers ‘On’: r =2.169, non-freezers ‘Off’:
r =2.087, non-freezers ‘On’: r =2.056, all p-values are non-
significant).
The three steps prior to a VR freezing episode in freezers ‘Off’
their medication were not characterized by a progressive reduction
in footstep latencies, with mean footstep latencies of: 0.998, 1.213
and 1.015 seconds for the steps 3, 2 and 1 before a VR freezing
episode, respectively. However, a greater STVVR was confirmed
in freezers ‘Off’ their medication when comparing the five steps
directly preceding a VR freeze with five randomly selected steps
that were unrelated to a VR freezing episodes (t (9) = 2.56,
p = 0.016).
Discussion
The aim of the current study was to determine whether a VR
task could reproduce the key features of gait variability associated
Exploring Stepping Variability in Freezing of Gait
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with FOG in PD [6–8,11]. Analysis of STVVR revealed major
similarities to those reported for stride time variability in previous
studies of patients performing actual gait tasks. Specifically, the
STVVR was greater in freezers compared to non-freezers and was
partially ameliorated by dopaminergic therapy. Additionally, there
was an increased STVVR just prior to a freezing episode, but we
were unable to demonstrate a sequence effect on latency across the
three steps directly preceding a freeze.
Both freezers and non-freezers showed increased variability in
their motor rhythm when withdrawn from dopaminergic medica-
tion. These results are consistent with previous work that has
shown that PD patients have a greater stride time variability in
their ‘Off’ state during a 6 m walking task in the home
environment [9]. In addition, Hausdorff et al [7] showed that the
stride time variability was reduced in response to L-dopa for both
freezers and non-freezers by using an 80 metre walking course and
force-sensitive insoles.
In the VR environment, freezers displayed greater temporal
variability in their stepping rhythm compared to non-freezers in
the ‘Off’ state, whilst the modal footstep latency did not differ
between the groups. These results mirror the findings of studies
showing that the stride CV is almost twice as high amongst
freezers compared to non-freezers, whilst the average stride times
do not differ between these patient groups [7,8].
The STVVR of the five steps preceding a virtual freezing episode
was explored by using a method based on the study by Moreau
et al [11]. That study assessed ten patients with FOG while they
walked down a 7-m walkway at high velocity while ‘Off’ their
regular medication. After determining the timing of the freezing
episodes, the investigators then compared the five pre-FOG steps
with five randomly chosen steps that were not associated with a
freezing episode (non-FOG). They found that the five steps leading
up to a freezing episode (pre-FOG) were characterized by
increased variability in length [11]. The current study showed a
similar pattern of results when comparing the STVVR of the pre-
FOG steps to the STVVR of the non-FOG steps in freezers ‘Off’
their medication.
Whilst the current study failed to demonstrate a shortening in
the footstep latencies of the three steps directly preceding a VR
freezing episode, it should be noted that this sequence effect has
previously been reported in the context of reducing stride length
rather than step timing. Future studies would be needed to
investigate whether a sequence effect is present in the amplitude of
the foot movements during the performance of the VR gait task.
Previous studies using the VR task [14,16,17] have included an
additional ‘dual-task performance’ along with a series of salient
environmental features (such as narrow doorways [14], both of
which are known to provoke freezing behaviour [29,30]. Instead,
Table 1. Demographic, neurological and freezing characteristics of subjects with and without freezing of gait.
Freezers (n =17) Non-freezers (n =11)
Mean 6 SD Median Range Mean 6 SD Median Range
Age 66.166.5 66 25 63.468.1 64 30
Disease duration (yr.) 7.2463.7 7.0 25 5.5563.1 4.0 11
LEDD 8076549 800 2400 5176427 450 1350
H & Y 1.8860.4 2.0 1.5 1.7760.6 2.0 1.5
UPDRS III ‘Off’ 32.4611 36 40 22.2611 24 38
UPDRS III ‘On’ 24.2614 22 44 12.566.7 11 19
MMSE 27.862.1 28 7.0 29.360.6 29 2.0
BDI-II 13.9611 14 42 7.4566.5 4.0 18
Modal FSL ‘Off’ 0.4260.2 0.37 0.55 0.4760.2 0.44 0.57
Modal FSL ‘On’ 0.4660.1 0.49 0.50 0.4660.1 0.44 0.44
FOG-Q 10.264.5 10 15 1.3061.4 1.0 4.0
NOTE: H & Y=Hoehn and Yahr stages, UPDRS III =motor section of the Unified Parkinson’s Disease Rating Scale, LEDD= Levodopa Equivalent Daily Dose (mg/day),
MMSE =Mini Mental State Examination, BDI-II = Beck’s Depression Inventory version II, Modal FSL =Modal Footstep Latency, FOG-Q= Freezing of Gait Questionnaire.
doi:10.1371/journal.pone.0066718.t001
Table 2. Differences in Step Time Variability in the Virtual Reality gait task (STVVR) between Freezers and Non-freezers and
between the ‘Off’ and ‘On’ states.
STVVR Median - Range STVVR Median - Range p-value
Group effect Freezers (n = 17) Non-freezers (n = 11)
‘Off’ 24.5–69.8 15.6–19.7 p = 0.032
‘On’ 13.5–48.4 11.8–15.7 p = 0.125
Medication ‘Off’ ‘On’
Freezers (n = 17) 24.5–69.8 13.5–48.4 p = 0.018
Non-freezers (n = 11) 15.6–19.7 11.8–15.7 p = 0.017
NOTE: Medication = differences between STVVR in the ‘Off’ and ‘On’ medication states.
doi:10.1371/journal.pone.0066718.t002
Exploring Stepping Variability in Freezing of Gait
PLOS ONE | www.plosone.org 4 June 2013 | Volume 8 | Issue 6 | e66718
the current study utilised only simple WALK and STOP cues,
removing the possibility of the influence of these added features.
However, despite this less challenging VR task, the present study
showed that freezers still had greater %FOG compared to non-
freezers in their ‘Off’ state and that freezers froze more in the ‘Off’
state compared to their ‘On’ state. These results highlight the role
of dopamine in the partial amelioration of freezing behaviour by
taking Levodopa, however it is not clear from the current study
whether such a positive benefit would be conferred onto patients
with ‘on’ freezing [31]. Despite this reservation, these results are
consistent with a large body of clinical research that shows that
FOG is exacerbated by low levels of dopaminergic medication [7–
10], and together with the results of previous work [32], even
supports the notion that the VR paradigm is capable of detecting
freezing episodes. However, we acknowledge that future research
should also combine the VR task with additional techniques, such
as accelerometry to determine whether the VR freezing observed
manifest features observed in FOG like ‘trembling in place’ [33].
The current study did not record actual gait parameters from
the subjects who were assessed with the VR gait task. This
approach would enhance the interpretability of the results
presented and will form the basis of future work. This study also
analyzed step time variability instead of stride time variability,
effectively including asymmetry in the measure of the within-
person standard deviation. Therefore the ‘gait asymmetry’ seen in
this study might have been concordant with the dominant
symptom side of the patients. However, analysis showed that
there were no differences in the average step times between the
left- and right foot for both freezers and non-freezers in both
medication states. This indicates that the results found in this study
were not due to an increased step time on the symptom dominant
side of the patients.
Moreover, to determine gait disturbances and to control for
differences in individual patient’s footstep latencies, all measures
were scaled to each patient’s modal footstep latency. These modal
footstep latencies were the same between freezers and non-freezers
and between the ‘Off’ and ‘On’ states for both groups. The groups
were also matched for the UPDRS-III scores, although non-
freezers displayed a slight bias towards less severe motoric disease
symptoms. Thus, the significant group differences reported were
unlikely to be related to general motor dysfunction and appear to
relate more specifically to some shared pathophysiology underly-
ing the phenomenon of FOG.
In conclusion, the VR gait task appears able to reproduce the
key features of stride time variability allowing for a model of
freezing of gait to be explored. Additional research is now needed
to complete this validation and it is hoped that this novel approach
may help in the understanding of the pathophysiology underlying
FOG.
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